T3 Pharmaceuticals Revenue

Biotechnology Research • Basel, Basel, Switzerland • 21-50 Employees

T3 Pharmaceuticals revenue & valuation

Annual revenue	$2,600,000
Revenue per employee	$90,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$8,400,000
Total funding	No funding

Key Contacts at T3 Pharmaceuticals

Simon Ittig

Ceo And Co-Founder

Christoph Kasper

Cso And Co-Founder

Marlise Amstutz

Executive Director Microbiology And Co-Founder

Company overview

Headquarters	c/o Biozentrum, Universität Basel, Klingelbergstr. 50/70, Basel, BS 4056, CH
Phone number	+41612672074
Website	t3pharma.com
NAICS	541714
SIC	283
Keywords	Biotechnology, Bacterial Cancer Therapy, Cancer Therapy, Protein Delivery
Founded	2015
Employees	21-50
Socials

T3 Pharmaceuticals Email Formats

T3 Pharmaceuticals uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@t3pharma.com), used 52.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@t3pharma.com	76.4%
{first initial}.{last name}	j.doe@t3pharma.com	23.5%

About T3 Pharmaceuticals

Developing the next generation bacterial cancer therapy The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria. T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of live bacteria. While the technology has diverse applications in research, T3 Pharma has further developed the system to serve as a novel therapeutic to treat solid tumors.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Head

Employees by Department

T3 Pharmaceuticals has 7 employees across 4 departments.

Departments

Number of employees

Funding Data

T3 Pharmaceuticals has never raised funding before.

T3 Pharmaceuticals Tech Stack

Discover the technologies and tools that power T3 Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

Popper

Miscellaneous

PHP

Programming languages

TYPO3 CMS

CMS

Bootstrap

UI frameworks

Google Maps

Maps

PhotoSwipe

JavaScript libraries

Microsoft 365

Frequently asked questions

T3 Pharmaceuticals is located in Basel, Basel, CH.

You can reach T3 Pharmaceuticals at +41612672074.

T3 Pharmaceuticals generates an estimated annual revenue of $2,600,000. This revenue figure reflects the company's market position and business performance in its industry.

T3 Pharmaceuticals has an estimated valuation of $8,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

T3 Pharmaceuticals was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

T3 Pharmaceuticals has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.